about
Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity.A cisplatin-loaded immuno-chemotherapeutic nanohybrid bearing immune checkpoint inhibitors for enhanced cervical cancer therapy.A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug.A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance.An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance.Monochalcoplatin: An Actively Transported, Quickly Reducible, and Highly Potent PtIV Anticancer ProdrugSynthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial FluorideSynthesis and Cytotoxic Study of a Platinum(IV) Anticancer Prodrug with Selectivity toward Luteinizing Hormone-Releasing Hormone (LHRH) Receptor-Positive Cancer Cells
P50
Q38823861-B60E2BF4-BF5C-44F7-9C0F-D9BB06A5DCD7Q48511650-27DAADEF-4E2D-4218-B6E8-AE2867D6F129Q50047013-DF982EF7-F111-4DD3-94FA-9CAD972DC9B1Q50750601-CA1C986F-26CE-4476-84D0-9809C2BD8C74Q50783492-2B852956-DF00-4664-9904-3823813E0759Q88879083-356FF5CA-D7B6-4841-A352-A420A0C6D9D4Q89256001-9F89E399-F662-479B-AA70-63224B08389EQ92493775-6B0DB925-E9B9-406F-ADEF-9364CE5BD14E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Zoufeng Xu
@ast
Zoufeng Xu
@en
Zoufeng Xu
@es
Zoufeng Xu
@nl
type
label
Zoufeng Xu
@ast
Zoufeng Xu
@en
Zoufeng Xu
@es
Zoufeng Xu
@nl
prefLabel
Zoufeng Xu
@ast
Zoufeng Xu
@en
Zoufeng Xu
@es
Zoufeng Xu
@nl
P106
P31
P496
0000-0001-5249-6392